Imexpharm Corporation (HOSE: IMP)

Imexpharm Revenue

Imexpharm had revenue of 517.22B VND in the quarter ending June 30, 2024, with 17.63% growth. This brings the company's revenue in the last twelve months to 2.08T, up 10.00% year-over-year. In the year 2023, Imexpharm had annual revenue of 1.99T with 21.31% growth.

• Revenue (ttm): 2,083.40B
• Revenue Growth: +10.00%
• P/S Ratio: 3.69
• Revenue / Employee: 1.45B
• Employees: 1,415
• Market Cap: 7,685.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,994.04B	350.33B	21.31%
Dec 31, 2022	1,643.71B	377.11B	29.77%
Dec 31, 2021	1,266.60B	-102.83B	-7.51%
Dec 31, 2020	1,369.42B	-33.03B	-2.36%
Dec 31, 2019	1,402.45B	217.64B	18.37%